Skip to main content
. 2021 Feb 1;12:642877. doi: 10.3389/fneur.2021.642877

Table 3.

Outcomes for patients with an A-shaped SVS compared to those with an S-shaped SVS.

All S-SVS A-SVS p-value
Number of patients (%) 62/62 (100%) 27/62 (44%) 35/62 (56%)
MT
  TICI 2b/2c/3 (%) 55 (89%) 26 (96%) 29 (83%) 0.09
  TICI 2c/3 (%) 31 (50%) 16 (59%) 15 (43%) 0.20
  TICI 0 (%) 0 (0%) 0 (0%) 0 (0%) 1
  TICI 1 (%) 1 (2%) 0 (0%) 1 (3%) 0.38
  TICI 2a (%) 6 (10%) 1 (4%) 5 (14%) 0.16
  TICI 2b (%) 24 (39%) 10 (37%) 14 (40%) 0.81
  TICI 2c (%) 13 (21%) 7 (26%) 6 (17%) 0.40
  TICI 3 (%) 18 (29%) 9 (33%) 9 (26%) 0.51
Complications (%) 5 (8%) 1 (4%) 4 (11%) 0.27
Groin/reperfusion time (min) 40 (24–71) 36 (25–62) 44 (23–77) 0.70
Onset/reperfusion time (min) 419 (306–519) 418 (249–545) 420 (312–484) 0.71
Early clinical outcome
  24 h NIHSS (median, IQR) 10 (5–16) 5 (2–15) 11 (7–18) 0.03
  NIHSS SHIFT (median, IQR) −7 (−11 to −1) −6 (−10 to −2) −7 (−11 to 0) 0.67
  Discharge NIHSS (median, IQR) 5 (2–13) 3 (2–9) 8 (3–18) 0.004
Long-term clinical outcome (55/62)
  3 months good mRS (0–1–2) (%) 28/55 (51%) 14/25 (56%) 14/30 (47%) 0.49
  3 months excellent mRS (0–1) (%) 18/55 (33%) 11/25 (44%) 7/30 (23%) 0.10
  3 months mortality (%) 13/55 (23%) 5/25 (20%) 8/30 (26%) 0.56